Klinické štúdie Lupus v štáte Kalifornia
27 štúdií pre Lupus hľadá účastníkov v zariadeniach v štáte Kalifornia.
Mestá v štáte Kalifornia
- Santa Monica8 štúdií
- Los Angeles8 štúdií
- San Diego7 štúdií
- Buena Park7 štúdií
- Fullerton5 štúdií
- San Francisco4 štúdií
- San Leandro3 štúdií
- Upland3 štúdií
- Sacramento3 štúdií
Oficiálny text štúdie (anglicky)
A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus Erythematosus
- Sl0044 50737, Beverly Hills
- Sl0044 50775, Beverly Hills
- Sl0044 50257, La Jolla
- a 6 ďalších
Prebieha náborFáza 3
Vek 16 a viac · Všetky pohlavia · Aktualizované 2. 10. 2026 · NCT06617325Study of Efficacy and Safety of LNP023 in Participants With Active Lupus Nephritis Class III-IV, +/- V
- Ronald Reagan UCLA Medical Center, Los Angeles
Prebieha náborFáza 2
Vek 18 až 100 · Všetky pohlavia · Aktualizované 1. 10. 2026 · NCT05268289A Study to Test Whether Different Doses of BI 3000202 Help People With Systemic Lupus Erythematosus (SLE)
- Wallace & Lee Center, Beverly Hills
- Arthritis & Osteoporosis Medical Center, Inc - La Palma, La Palma
- University of California San Diego, San Diego
- a 3 ďalších
Prebieha náborFáza 2
Vek 18 až 74 · Všetky pohlavia · Aktualizované 1. 10. 2026 · NCT07409181Phase 3 Extension Study to Evaluate Long-term Safety of Ianalumab in Participants With Systemic Lupus Erythematosus (SIRIUS-SLE Extension).
- Providence Medical Center, Burbank
- Advanced Medical Research, La Palma
Prebieha náborFáza 3
Vek 12 až 100 · Všetky pohlavia · Aktualizované 1. 10. 2026 · NCT06133972An Efficacy and Safety Study of Intravenous Anifrolumab to Treat Systemic Lupus Erythematosus in Pediatric Participants
- Research Site, Los Angeles
Prebieha náborFáza 3
Vek 5 až 17 · Všetky pohlavia · Aktualizované 30. 9. 2026 · NCT05835310A Study to Evaluate the Treatment Outcomes of Subcutaneous Anifrolumab in Immunosuppressant-naïve and Biologic-naïve Systemic Lupus Erythematosus
- Research Site, Fontana
- Research Site, La Jolla
- Research Site, La Palma
- a 3 ďalších
Prebieha náborFáza 3
Vek 18 až 70 · Všetky pohlavia · Aktualizované 25. 9. 2026 · NCT07430306A Study of Nipocalimab in Adults With Moderate to Severe Systemic Lupus Erythematosus
- David S Hallegua MD A Professional Corporation, Beverly Hills
- Providence Medical Foundation, Fullerton
- Southland Arthritis and Osteoporosis Medical Center Inc dba Southland Arthritis, Hemet
- a 5 ďalších
Prebieha náborFáza 3
Vek 18 až 75 · Všetky pohlavia · Aktualizované 25. 9. 2026 · NCT07438496A Study to Assess Adverse Events, How the Drug Moves Through the Body and Effectiveness of Intravenous Infusions and Subcutaneous Injections of ABBV-519 in Adult Participants With Systemic Lupus Erythematosus (SLE) or Rheumatoid Arthritis (RA)
- Solace Research /ID# 279155, Tustin
Prebieha náborFáza 1
Vek 18 až 75 · Všetky pohlavia · Aktualizované 25. 9. 2026 · NCT07607964Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
- University of California Davis Comprehensive Cancer Center, Sacramento
Prebieha náborFáza 1
Vek 18 a viac · Všetky pohlavia · Aktualizované 23. 9. 2026 · NCT03816345Study Evaluating Safety, Tolerability, PK/PD of Surovatamig in Adult RA or SLE Participants
- Research Site, Fullerton
Prebieha náborFáza 1
Vek 18 až 65 · Všetky pohlavia · Aktualizované 18. 9. 2026 · NCT07201558A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD5492 in Adult Participants With Systemic Lupus Erythematosus or Idiopathic Inflammatory Myopathies or Rheumatoid Arthritis.
- Research Site, La Jolla
- Research Site, Sacramento
Prebieha náborFáza 1
Vek 18 až 70 · Všetky pohlavia · Aktualizované 15. 9. 2026 · NCT06916806Dose Escalation Study With Bispecific Antibodies in Adult Participants With Lupus Nephritis
- University of California San Francisco - Zuckerberg San Francisco General, San Francisco
Prebieha náborFáza 1
Vek 18 až 60 · Všetky pohlavia · Aktualizované 14. 9. 2026 · NCT06975787A Study of Enpatoran in Participants With Cutaneous Manifestations of Lupus With or Without Systemic Disease (ELOWEN-2)
- Inland Rheumatology Clinical Trials, Inc., Upland
Prebieha náborFáza 3
Vek 18 až 75 · Všetky pohlavia · Aktualizované 14. 9. 2026 · NCT07355218A Phase 2, Open-Label, Single-Arm Trial of FT819 in Participants With Lupus Nephritis
- Wallace Rheumatic Studies Center, Beverly Hills
- Kaiser Permanente Fontana, Fontana
- Providence Medical Foundation, Fullerton
- a 2 ďalších
Prebieha náborFáza 2
Vek 12 až 70 · Všetky pohlavia · Aktualizované 14. 9. 2026 · NCT07570862A Study of Enpatoran in Participants With Cutaneous Manifestations of Lupus With or Without Systemic Disease
- Dermatology Research Associates - 300204025, Los Angeles
- Cohen Medical Centers, Thousand Oaks
Prebieha náborFáza 3
Vek 18 až 75 · Všetky pohlavia · Aktualizované 11. 9. 2026 · NCT07332481A Study to Investigate the Safety, Tolerability, and Efficacy of AZD0120 in Adults With Refractory SLE
- Research Site, San Francisco
- Research Site, Stanford
Prebieha náborFáza 1/2
Vek 18 až 70 · Všetky pohlavia · Aktualizované 10. 9. 2026 · NCT06897930A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease
- Loma Linda University Medical Center, Loma Linda
Prebieha náborFáza 1
Vek 18 až 74 · Všetky pohlavia · Aktualizované 10. 9. 2026 · NCT07085104A Study in Participants With Active Systemic Lupus Erythematosus With Inadequate Response to Glucocorticoids and ≥2 Immunosuppressants
- Local Institution - 0054, La Jolla
- Local Institution - 0001, La Palma
- Local Institution - 0071, Los Angeles
- a 1 ďalších
Prebieha náborObservačná štúdia
Vek 16 a viac · Všetky pohlavia · Aktualizované 3. 9. 2026 · NCT07175285FT839 in Autoimmune Diseases
- Providence Medical Foundation, Fullerton
Prebieha náborFáza 1/2
Vek 18 až 70 · Všetky pohlavia · Aktualizované 2. 9. 2026 · NCT07800871A Safety and Efficacy Study Evaluating CTX112 in Adult Subjects With Refractory Autoimmune Disease
- UC San Diego Health, La Jolla
- Stanford University Medical Center, Redwood City
Prebieha náborFáza 1
Vek 18 až 70 · Všetky pohlavia · Aktualizované 28. 8. 2026 · NCT06925542RESET-SLE: A Phase 1/2 Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Systemic Lupus Erythematosus
- University of California Irvine, Orange
- UC Davis Health, Sacramento
Prebieha náborFáza 1/2
Vek 18 až 65 · Všetky pohlavia · Aktualizované 26. 8. 2026 · NCT06121297Effects of Stopping Hydroxychloroquine in Elderly Lupus Disease
- University of California, Los Angeles, Los Angeles
- University of California: San Diego, San Diego
Prebieha náborFáza 3
Vek 55 a viac · Všetky pohlavia · Aktualizované 20. 8. 2026 · NCT05799378A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 2a Study With an Open-Label Extension Evaluating the Efficacy and Safety of VENT-03 in Adult Participants With Active Cutaneous Lupus Erythematosus With or Without Systemic Lupus Erythematosus
- Investigative Site, Beverly Hills
Prebieha náborFáza 2
Vek 18 až 80 · Všetky pohlavia · Aktualizované 27. 7. 2026 · NCT07260877Phase 1a/b Tolerability of NTR-1011 in Healthy Adults and Adult Patients With SLE and RA
- Carewell Arthritis Center, Apple Valley
- Attune Health Research Inc, Beverly Hills
- Covina Arthritis Clinic, Covina
- a 4 ďalších
Prebieha náborFáza 1
Vek 18 až 75 · Všetky pohlavia · Aktualizované 20. 7. 2026 · NCT07237659A Phase 1/2a Study of DB-2304 in Healthy Adults and SLE/CLE Participants
- US06-0, La Palma
Prebieha náborFáza 1/2Vítaní zdravých dobrovoľníkov
Vek 18 až 70 · Všetky pohlavia · Aktualizované 2. 6. 2026 · NCT06625671A Phase 1 Study of FT819 in B-cell Mediated Autoimmune Disease
- Wallace Rheumatic Center, Beverly Hills
- Providence Medical Foundation, Fullerton
- University of California Irvine, Irvine
- a 2 ďalších
Prebieha náborFáza 1
Vek 12 až 70 · Všetky pohlavia · Aktualizované 22. 5. 2026 · NCT06308978Lupus Landmark Study: A Prospective Registry and Biorepository
- Wallace Rheumatic Studies Center, Beverly Hills
- UCLA, Los Angeles
Prebieha náborObservačná štúdia
Vek 18 až 110 · Všetky pohlavia · Aktualizované 15. 4. 2026 · NCT05934149Z ClinicalTrials.gov, dáta načítané 5. 10. 2026. Každá štúdia má vlastné kritériá oprávnenosti; tím štúdie rozhoduje o účasti.